ANNX Annexon Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ANNX

Price (delayed)

$4.74

Market cap

$426.72M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.77

Enterprise value

$231.93M

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on ...

Highlights
The equity has surged by 60% since the previous quarter and by 8% year-on-year
Annexon's quick ratio has soared by 50% from the previous quarter and by 33% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.annexonbio.com
Peers: OMER OMGA

Key stats

What are the main financial stats of ANNX
Market
Shares outstanding
90.03M
Market cap
$426.72M
Enterprise value
$231.93M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.01
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$134.24M
EBITDA
-$130.97M
Free cash flow
-$121.34M
Per share
EPS
-$1.77
Free cash flow per share
-$1.6
Book value per share
$4.71
Revenue per share
$0
TBVPS
$3.93
Balance sheet
Total assets
$297.67M
Total liabilities
$47.12M
Debt
$31.36M
Equity
$250.56M
Working capital
$245.93M
Liquidity
Debt to equity
0.13
Current ratio
14.72
Quick ratio
14.54
Net debt/EBITDA
1.49
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-53.5%
Return on equity
-66.5%
Return on invested capital
-123.5%
Return on capital employed
-48%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANNX stock price

How has the Annexon stock price performed over time
Intraday
4.18%
1 week
6.52%
1 month
-28.51%
1 year
-13.03%
YTD
4.41%
QTD
-33.89%

Financial performance

How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$143.72M
Net income
-$134.24M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 5% YoY and by 4.6% QoQ
The company's operating income rose by 4.4% QoQ

Growth

What is Annexon's growth rate over time

Valuation

What is Annexon stock price valuation
P/E
N/A
P/B
1.01
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has increased by 32% YoY and by 2.2% QoQ
The equity has surged by 60% since the previous quarter and by 8% year-on-year
The P/B is 8% higher than the last 4 quarters average of 0.9

Efficiency

How efficient is Annexon business performance
The return on invested capital has declined by 20% year-on-year and by 11% since the previous quarter
The ROE is up by 7% since the previous quarter
ANNX's ROA is up by 6% QoQ

Dividends

What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANNX.

Financial health

How did Annexon financials performed over time
Annexon's quick ratio has soared by 50% from the previous quarter and by 33% YoY
Annexon's current ratio has increased by 49% from the previous quarter and by 33% YoY
Annexon's debt is 87% less than its equity
The equity has surged by 60% since the previous quarter and by 8% year-on-year
The debt to equity has declined by 35% since the previous quarter and by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.